Templeman Blaine 4
4 · ADURO BIOTECH, INC. · Filed May 21, 2018
Insider Transaction Report
Form 4
Templeman Blaine
Executive VP, General Counsel
Transactions
- Sale
Common Stock
2018-05-17$8.15/sh−2,000$16,300→ 69,937 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 9, 2018.
- [F2]The shares sold were originally acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2018.